LUVERIS 75 IU Infusion
Lutropin alfa
75 IU
LABORATOIRES SERONO SA
| Pack size | 1 Vial (Dry) + 1 Solvent Vial (1ml) |
|---|---|
| Dispensing mode | POM |
| Source | SWITZERLAND |
| Agent | ARABIAN ETHICALS CO. |
| Retail Price | 161.50 AED |
Indications
LUVERIS 75 IU Infusion is used for:
For treatment of infertility in women with hypothalamic or pituitary insufficiency (hypogonadotropic hypogonadism) and profound LH deficiency (LH <1.2 international units [IU]/L)
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Lutropin alfa :
Mechanism of Action
Luteinizing hormone binds to a receptor shared with the human chorionic gonadotropin hormone (hCG) on the ovarian theca (and granulosa) cells and testicular Leydig cells. This LH/CG transmembrane receptor is a member of the super-family of G protein-coupled receptors. Adenylate cyclase then activates many other pathways leading to steroid hormone production and other follicle maturation processes.
Note
LUVERIS 75 IU 75 IU Infusion manufactured by LABORATOIRES SERONO SA. Its generic name is Lutropin alfa. LUVERIS 75 IU is availble in United Arab Emirates.
Farmaco UAE drug index information on LUVERIS 75 IU Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.